Levofloxacin Orion

Levofloxacin, the active ingredient in Levofloxacin Orion, is a fluoroquinolone antibiotic presented as an oral tablet for oral use. It treats a range of bacterial infections in adults, including respiratory, urinary and skin infections. The drug works by inhibiting bacterial DNA replication, providing broad‑spectrum coverage against Gram‑negative and Gram‑positive pathogens.

GNH USA supplies Levofloxacin Orion as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levofloxacin is a broad‑spectrum fluoroquinolone used to treat bacterial infections in various organ systems.

- Community‑acquired pneumonia: reduces bacterial load and improves clinical symptoms in adult patients. - Acute bacterial sinusitis: eradicates causative pathogens and relieves sinus inflammation. - Acute exacerbations of chronic bronchitis: shortens disease course and prevents complications. - Urinary tract infections: eliminates uropathogens and resolves urinary symptoms. - Skin and soft tissue infections: clears bacterial invasion and promotes wound healing.

Levofloxacin may cause a variety of adverse reactions, ranging from mild to severe.

Common Side Effects: - Nausea: mild gastrointestinal upset occurring in many patients. - Diarrhea: loose stools that are usually self‑limiting. - Headache: transient cranial discomfort. - Dizziness: occasional vertigo or light‑headedness. - Insomnia: difficulty falling or staying asleep. - Rash: mild skin erythema or pruritus.

Serious or Rare Side Effects: - Tendon rupture: especially Achilles tendon, requiring immediate discontinuation. - QT interval prolongation: may predispose to cardiac arrhythmias. - Severe allergic reactions: anaphylaxis, angioedema, or Stevens‑Johnson syndrome. - Clostridioides difficile infection: colitis due to disruption of gut flora. - Hepatic toxicity: elevated liver enzymes or hepatitis. - Peripheral neuropathy: numbness or tingling in extremities.

Before initiating therapy, clinicians should evaluate patient‑specific risk factors and monitor for potential complications.

- Assess renal function: adjust use in patients with impaired clearance. - Avoid in known fluoroquinolone hypersensitivity: discontinue if allergic signs appear. - Monitor for tendon pain: stop therapy at the first indication of tendon inflammation. - Use caution in elderly: higher incidence of central nervous system effects. - Store at room temperature: keep in the original pack, protect from moisture and light.

Levofloxacin can alter the pharmacokinetics or pharmacodynamics of several co‑administered drugs.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: reduce levofloxacin absorption. - Warfarin: may increase anticoagulant effect and bleeding risk. - Corticosteroids: heightened risk of tendon rupture. - Cyclosporine: may raise serum levofloxacin concentrations. - Theophylline: increased plasma levels leading to toxicity.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs: may augment central nervous system toxicity. - Diabetes medications: possible alteration of glucose control. - Proton pump inhibitors: modestly decrease levofloxacin absorption. - Rifampin: may lower levofloxacin plasma concentrations. - Oral contraceptives: potential reduction in contraceptive efficacy.